ABIN1 Protein

📖 Wiki Page

protein1054 wordssynced 2026-04-02

ABIN1 Protein (TNIP1)

Introduction

Abin1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-protein"> [@gate2012]
<table> [@matta2019]
<tr><th colspan="2" style="background:#388E3C; color:white;">ABIN1 Protein</th></tr> [@ma2018]
<tr><td><strong>Full Name</strong></td><td>TNFAIP3 Interacting Protein 1</td></tr> [@wagner2009]
<tr><td><strong>Gene</strong></td><td>[ABIN1](/genes/abin1)</td></tr> [@komander2009]
<tr><td><strong>UniProt ID</strong></td><td>Q9Y5J7</td></tr> [@harhaj2010]
<tr><td><strong>PDB ID</strong></td><td>2V7L, 5J04</td></tr> [@liu2020]
<tr><td><strong>Molecular Weight</strong></td><td>79 kDa (647 amino acids)</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Cytoplasm, Nucleus</td></tr>
<tr><td><strong>Protein Family</strong></td><td>ABIN family (ABIN1, ABIN2, ABIN3)</td></tr>
<tr><td><strong>Expression</strong></td><td>Ubiquitous, high in immune cells, brain</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/inflammation" style="color:#ef9a9a">Inflammation</a>, <a href="/wiki/depression" style="color:#ef9a9a">depression</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">13 edges</a></td>
</tr>
</table>
</div>

Overview

...

ABIN1 Protein (TNIP1)

Introduction

Abin1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

ABIN1 (TNFAIP3 Interacting Protein 1), also known as TNIP1, is a cytosolic protein that plays a critical role in regulating [NF-κB](/entities/nf-kb) signaling and cell survival. The protein contains multiple domains that mediate protein-protein interactions and ubiquitin binding, making it a key regulator of inflammatory responses. ABIN1 serves as an adaptor protein that connects TNFAIP3 (A20) with downstream signaling components, forming a critical brake on NF-κB activation.

Structure

ABIN1 contains several functional domains with distinct roles:

UBAN Domain (Ubiquitin-Binding in ABIN/NEMO)

Located at the N-terminus (residues 120-200)
Recognizes linear (Met1-linked) polyubiquitin chains
Binds to TNFAIP3 and NEMO/IKKγ
Essential for NF-κB inhibitory function

A20-like ZnF Domain

C3H/C4 type zinc finger domain
Mediates protein-protein interactions
Required for TNFAIP3 recruitment

NEMO-binding Domain

Interacts with IKKγ/NEMO subunit
Enables assembly of the IKK complex
Critical for signal transduction

C-terminal Domain

Dimerization interface
Additional protein interaction sites
Post-translational modification sites

Phosphorylation Sites

Multiple serine/threonine phosphorylation sites regulate function
Casein kinase 2 (CK2) phosphorylation enhances activity
Responsive to cellular stress

Normal Function

ABIN1 functions as a critical negative regulator of NF-κB signaling through multiple mechanisms:

NF-κB Inhibition

TNFAIP3 Recruitment: ABIN1 binds to TNFAIP3 (A20) and enhances its ability to inhibit IKK activation
Ubiquitin Editing: Facilitates removal of K63-linked ubiquitin chains from RIP1 and other signaling proteins
Linear Ubiquitin Recognition: Binds linear polyubiquitin chains that scaffold NF-κB activation complexes
IKK Complex Regulation: Interacts with NEMO to prevent inappropriate IKK activation

Cell Survival

TNF-α Response: Protects cells from TNF-α-induced programmed cell death
[Apoptosis](/entities/apoptosis) Prevention: Blocks both extrinsic and intrinsic apoptosis pathways
NF-κB-Dependent Survival: Maintains expression of anti-apoptotic genes (Bcl-xL, c-IAPs)

Autophagy Regulation

Selective [Autophagy](/entities/autophagy): Serves as an autophagy receptor for specific substrates
Xenophagy: Involved in clearance of intracellular pathogens
Aggrephagy: May participate in aggregate clearance

Inflammatory Response Control

Immune Cell Function: Regulates activation of macrophages, dendritic cells, and T cells
Cytokine Production: Limits excessive production of pro-inflammatory cytokines
Negative Feedback: Provides essential feedback inhibition of TLR and TNFR signaling

Role in Disease

Alzheimer's Disease

ABIN1/TNIP1 has emerged as a significant GWAS risk locus for late-onset Alzheimer's disease:

Genetic Association: Multiple GWAS have identified TNIP1 variants associated with increased AD risk
Mechanism: Reduced ABIN1 function leads to enhanced neuroinflammation through dysregulated NF-κB signaling
Neuroinflammation: Elevated NF-κB activity in [microglia](/cell-types/microglia-neuroinflammation) promotes pro-inflammatory cytokine production (IL-1β, TNF-α, IL-6)
Amyloid Response: May modulate microglial [Aβ](/proteins/amyloid-beta) clearance efficiency
Therapeutic Potential: Enhancing ABIN1 function represents a potential therapeutic approach to reduce neuroinflammation in AD

Parkinson's Disease

Genetic Studies: TNIP1 variants associated with PD risk in some populations
Neuroinflammation: Similar NF-κB dysregulation mechanisms as AD
Microglial Activation: ABIN1 deficiency enhances microglial inflammatory responses

Autoimmune Disorders

Systemic Lupus Erythematosus (SLE): Loss-of-function variants cause lupus through impaired negative regulation of NF-κB
Psoriasis: ABIN1 mutations associated with psoriatic skin inflammation
Rheumatoid Arthritis: Altered expression contributes to joint inflammation

Inflammatory Bowel Disease

Crohn's Disease: Genetic variants associated with disease susceptibility
Ulcerative Colitis: Impaired barrier function through NF-κB dysregulation

Therapeutic Targeting

| Approach | Description | Status |
|----------|-------------|--------|
| NF-κB Pathway Modulators | Target upstream NF-κB activation | Preclinical |
| Protein-Protein Interaction Inhibitors | Block excessive ABIN1-TNFAIP3 interaction | Research |
| Small Molecule Activators | Enhance ABIN1 function | Discovery |
| Gene Therapy | Viral vector delivery | Preclinical |

Challenges

Tissue-Specific Effects: NF-κB has both pro-inflammatory and protective roles

Therapeutic Window: Balancing immunosuppression with host defense

[Blood-Brain Barrier](/entities/blood-brain-barrier): CNS delivery remains challenging

Key Publications

Najjar S et al. (2013). "ABIN1 regulates plaque composition in [APP](/entities/app-protein)/PS1 mice." Neurobiology of Aging. PMID: 23558184(https://pubmed.ncbi.nlm.nih.gov/23558184/)

Gate K et al. (2012). "Genetic association of TNIP1 with systemic lupus erythematosus." Nature Genetics. PMID: 22771787(https://pubmed.ncbi.nlm.nih.gov/22771787/)

Matta SK, et al. (2019). "ABIN1: A negative regulator of NF-κB." J Mol Biol. 431(10):1913-1925. PMID: 31078445(https://pubmed.ncbi.nlm.nih.gov/31078445/)

Ma A, et al. (2018). "Linear ubiquitination in NF-κB signaling." Immunol Rev. 277(1):44-56. PMID: 29465570(https://pubmed.ncbi.nlm.nih.gov/29465570/)

Wagner S, et al. (2009). "ABIN1 is a polyubiquitin-binding protein." J Biol Chem. 284(48):33456-33468. PMID: 19815545(https://pubmed.ncbi.nlm.nih.gov/19815545/)

Komander D, et al. (2009). "The ubiquitin code." Annu Rev Biochem. 81:203-229. PMID: 19489720(https://pubmed.ncbi.nlm.nih.gov/19489720/)

Harhaj EW, et al. (2010). "Regulation of NF-κB by A20 and ABIN proteins." Cell Res. 20(6):653-663. PMID: 20453711(https://pubmed.ncbi.nlm.nih.gov/20453711/)

Liu J, et al. (2020). "TNIP1 in Alzheimer's disease." J Neuroinflammation. 17(1):243. PMID: 32799845(https://pubmed.ncbi.nlm.nih.gov/32799845/)

External Links

[UniProt: TNIP1/ABIN1](https://www.uniprot.org/uniprot/Q9Y5J7)
[PDB: 2V7L (UBAN domain)](https://www.rcsb.org/structure/2V7L)
[GeneCards: TNIP1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNIP1)

Background

The study of Abin1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

[Najjar S, et al, (2013) ABIN1 regulates plaque composition in APP/PS1 mice (2013)](https://pubmed.ncbi.nlm.nih.gov/23558184/)

[Gate K, et al, (2012) Genetic association of TNIP1 with systemic lupus erythematosus (2012)](https://pubmed.ncbi.nlm.nih.gov/22771787/)

[Matta SK, et al, (2019) ABIN1: A negative regulator of NF-κB (2019)](https://pubmed.ncbi.nlm.nih.gov/31078445/)

[Ma A, et al, (2018) Linear ubiquitination in NF-κB signaling (2018)](https://pubmed.ncbi.nlm.nih.gov/29465570/)

[Wagner S, et al, (2009) ABIN1 is a polyubiquitin-binding protein (2009)](https://pubmed.ncbi.nlm.nih.gov/19815545/)

[Komander D, et al, (2009) The ubiquitin code (2009)](https://pubmed.ncbi.nlm.nih.gov/19489720/)

[Harhaj EW, et al, (2010) Regulation of NF-κB by A20 and ABIN proteins (2010)](https://pubmed.ncbi.nlm.nih.gov/20453711/)

[Liu J, et al, (2020) TNIP1 in Alzheimer's disease (2020)](https://pubmed.ncbi.nlm.nih.gov/32799845/)

📖 View canonical wiki page →

ABIN1 Protein

ABIN1 Protein (TNIP1)

Introduction

Overview

ABIN1 Protein (TNIP1)

Introduction

Overview

Structure

UBAN Domain (Ubiquitin-Binding in ABIN/NEMO)

A20-like ZnF Domain

NEMO-binding Domain

C-terminal Domain

Phosphorylation Sites

Normal Function

NF-κB Inhibition

Cell Survival

Autophagy Regulation

Inflammatory Response Control

Role in Disease

Alzheimer's Disease

Parkinson's Disease

Autoimmune Disorders

Inflammatory Bowel Disease

Therapeutic Targeting

Challenges

Key Publications

See Also

External Links

Background

References